---
figid: PMC9553391__OMCL2022-8965903.008
figtitle: Anlotinib Benefits the APDL1 Immunotherapy by Activating ROS/JNK/AP-1 Pathway
  to Upregulate PDL1 Expression in Colorectal Cancer
organisms:
- NA
pmcid: PMC9553391
filename: OMCL2022-8965903.008.jpg
figlink: /pmc/articles/PMC9553391/figure/fig8/
number: F8
caption: Schematic diagram of anlo-induced PDL1, IFN-α/β/γ, and CXCL2 expression in
  mouse CRC cells. Anlo increased ROS, leading to activate JNK/AP-1/interferon signaling
  pathway. Meanwhile, AP-1/interferons contributed to the upregulation of PDL1, INF-α/β/γ,
  and CXCL2.
papertitle: Anlotinib Benefits the αPDL1 Immunotherapy by Activating ROS/JNK/AP-1
  Pathway to Upregulate PDL1 Expression in Colorectal Cancer.
reftext: Bixian Luo, et al. Oxid Med Cell Longev. 2022;2022:8965903.
year: '2022'
doi: 10.1155/2022/8965903
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.9624911
figid_alias: PMC9553391__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9553391__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9553391__OMCL2022-8965903.008.html
  '@type': Dataset
  description: Schematic diagram of anlo-induced PDL1, IFN-α/β/γ, and CXCL2 expression
    in mouse CRC cells. Anlo increased ROS, leading to activate JNK/AP-1/interferon
    signaling pathway. Meanwhile, AP-1/interferons contributed to the upregulation
    of PDL1, INF-α/β/γ, and CXCL2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JUN
  - JUNB
  - JUND
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - MAPK8
  - MAPK9
  - MAPK10
  - IFNA1
  - IFNK
  - IFNW1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - CXCL2
---
